A detailed history of Ubs Group Ag transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Ubs Group Ag holds 90,000 shares of EW stock, worth $6.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
90,000
Previous 1,657,890 94.57%
Holding current value
$6.1 Million
Previous $153 Million 96.12%
% of portfolio
0.0%
Previous 0.04%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$59.7 - $93.78 $7.9 Million - $12.4 Million
132,265 Added 7.98%
1,790,155 $118 Million
Q2 2024

Aug 13, 2024

BUY
$84.3 - $94.31 $19.9 Million - $22.2 Million
235,704 Added 16.57%
1,657,890 $153 Million
Q1 2024

May 13, 2024

BUY
$72.54 - $95.56 $216,314 - $284,959
2,982 Added 0.21%
1,422,186 $136 Million
Q4 2023

Feb 09, 2024

SELL
$61.71 - $77.76 $58.7 Million - $74 Million
-951,132 Reduced 40.13%
1,419,204 $108 Million
Q3 2023

Nov 09, 2023

BUY
$69.28 - $93.38 $20,922 - $28,200
302 Added 0.01%
2,370,336 $164 Million
Q2 2023

Aug 11, 2023

BUY
$81.41 - $94.33 $18.1 Million - $21 Million
222,623 Added 10.37%
2,370,034 $224 Million
Q1 2023

May 12, 2023

SELL
$74.26 - $84.51 $12.1 Million - $13.8 Million
-162,808 Reduced 7.05%
2,147,411 $178 Million
Q4 2022

Feb 08, 2023

SELL
$68.3 - $87.44 $3.98 Million - $5.1 Million
-58,311 Reduced 2.46%
2,310,219 $172 Million
Q3 2022

Nov 10, 2022

SELL
$82.37 - $107.29 $12 Million - $15.6 Million
-145,446 Reduced 5.79%
2,368,530 $196 Million
Q2 2022

Aug 10, 2022

BUY
$86.5 - $128.27 $1.38 Million - $2.05 Million
15,991 Added 0.64%
2,513,976 $239 Million
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $36.9 Million - $46.5 Million
-362,168 Reduced 12.66%
2,497,985 $294 Million
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $26.5 Million - $32.6 Million
249,083 Added 9.54%
2,860,153 $371 Million
Q3 2021

Nov 15, 2021

SELL
$102.91 - $122.75 $14.5 Million - $17.3 Million
-141,213 Reduced 5.13%
2,611,070 $296 Million
Q2 2021

Aug 13, 2021

BUY
$83.84 - $104.76 $15.4 Million - $19.2 Million
183,669 Added 7.15%
2,752,283 $285 Million
Q1 2021

May 12, 2021

BUY
$78.68 - $90.67 $21.4 Million - $24.6 Million
271,440 Added 11.82%
2,568,614 $215 Million
Q4 2020

Feb 11, 2021

BUY
$71.69 - $91.23 $19.3 Million - $24.6 Million
269,770 Added 13.31%
2,297,174 $210 Million
Q3 2020

Nov 12, 2020

BUY
$67.19 - $87.44 $13.2 Million - $17.2 Million
196,543 Added 10.74%
2,027,404 $162 Million
Q2 2020

Jul 31, 2020

BUY
$57.54 - $76.95 $67 Million - $89.6 Million
1,163,972 Added 174.54%
1,830,861 $127 Million
Q1 2020

May 01, 2020

SELL
$52.41 - $81.0 $2.22 Million - $3.42 Million
-42,267 Reduced 5.96%
666,889 $126 Million
Q4 2019

Feb 14, 2020

SELL
$71.7 - $82.09 $6.61 Million - $7.57 Million
-92,235 Reduced 11.51%
709,156 $165 Million
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $911,555 - $1.12 Million
-14,810 Reduced 1.81%
801,391 $176 Million
Q2 2019

Aug 14, 2019

SELL
$55.74 - $64.41 $2.73 Million - $3.15 Million
-48,924 Reduced 5.66%
816,201 $151 Million
Q1 2019

May 14, 2019

BUY
$47.89 - $64.05 $2.24 Million - $2.99 Million
46,695 Added 5.71%
865,125 $166 Million
Q4 2018

Feb 14, 2019

SELL
$46.41 - $56.94 $634,239 - $778,142
-13,666 Reduced 1.64%
818,430 $125 Million
Q3 2018

Nov 14, 2018

BUY
$45.7 - $58.03 $941,374 - $1.2 Million
20,599 Added 2.54%
832,096 $145 Million
Q2 2018

Aug 14, 2018

BUY
$42.45 - $51.3 $1.56 Million - $1.89 Million
36,782 Added 4.75%
811,497 $118 Million
Q1 2018

May 15, 2018

SELL
$37.19 - $47.45 $3.12 Million - $3.99 Million
-83,987 Reduced 9.78%
774,715 $108 Million
Q4 2017

Feb 14, 2018

BUY
$33.79 - $39.39 $170,707 - $198,998
5,052 Added 0.59%
858,702 $96.8 Million
Q3 2017

Nov 14, 2017

SELL
$36.29 - $38.83 $2.11 Million - $2.26 Million
-58,111 Reduced 6.37%
853,650 $93.3 Million
Q2 2017

Aug 14, 2017

BUY
N/A
38,068 Added 4.36%
911,761 $108 Million
Q1 2017

Nov 14, 2017

BUY
N/A
873,693
873,693 $82.2 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.